Clinical trial

A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II…

NCT00190528 · Haruhiko Fukuda, Other · Terminated

Key facts

NCT number NCT00190528
Title A Trial of Neoadjuvant Chemotherapy + Surgery vs. Surgery for Bulky Stage I/II Cervical Cancer
Official title Phase III Trial of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Bulky Stage I/II Cervical Cancer: Japan Clinical Oncology Group Trial (JCOG0102)
Lead sponsor Haruhiko Fukuda, Other
Collaborators Ministry of Health, Labour and Welfare, Japan
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Cervical Neoplasms
Intervention type Drug, Procedure
Interventions neoadjuvant chemotherapy + radical hysterectomy, radical hysterectomy
Enrollment 200
Start date Feb 1, 2002
Primary completion Dec 1, 2004
Completion Feb 1, 2009
First posted Sep 19, 2005
Last update posted Sep 22, 2016
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies